CytoDyn Inc. (OTCMKTS:CYDY) may be the target of a White House press briefing very soon. A couple of social media influencers like...
RIGL stock exploded higher last month after instigating an investigator-sponsored trial (IST) with the Imperial College London to evaluate the effi...
Tonix Pharmaceuticals is a name that we covered last month before its run to $2.50, which you can read here. What attracted...
No one ever said investing is easy. The key is doing lots of research and finding momentum BEFORE it happens. We did...
ATOS stock is a name that we covered on and off since 2017. Except for a few price spikes, ATOS stock has been...
VBI Vaccines stock has dropped along with the other COVID-19 vaccine players after Russia announced it developed a coronavirus vaccine. Like many...
A thorn in the side of longs continues to be Hindenburg Research. Whenever a hot stock starts climbing, Hindenburg goes short and...
BCRX stock ran to $6 after re-initiated coverage last month, which you can read here. Since then, BCRX has dropped back down...
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
Price action is very important when it comes to trading and investing. On a day when COVID-19 vaccine plays dropped on the...